| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Tudor Pop
Cynthia McLaughlin
Omar Beirat
| Share Statistics | PODD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,186.1 | $407.7 | 78% |
|
| Shares Out (Mil) | 69.4 | 41.3 | 55% |
|
| Institutional Ownership | 99.7% | 81.4% | 92% |
|
| Float (Mil) | 69.1 | 34.9 | 54% |
|
| Beta | 1.09 | 0.88 | 66% |
|
| Avg Daily Volume (000s) | 1,417 | 412 | 76% |
|
| Price Change (52-week) |
(55.2%) | 64.8% | 13% |
|
| Growth | PODD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 24.5% | 11.8% | 86% |
|
| Net Income (5yr) | 105.2% | (6.0%) | 99% |
|
| EPS (5yr) | 103.4% | 10.4% | 99 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.2%) | (16.2%) | 38% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 21 | 23 | 23 | |
| Current EPS | $1.587 | $6.503 | $7.711 | |
| Month Ago EPS | $1.633 | $6.478 | $8.054 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | $1.635 | $6.471 | $8.059 | |
| Year/Year Chg | 15.8% | 86.9% | 166.9% | |
| Financials | PODD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,053 | $119 | 66% |
|
| Net Income (TTM) (Mil) | $375 | ($9) | 75% |
|
| EPS (TTM) | $5.361 | ($0.400) | 87% |
|
| Operating Cash Flow (TTM) (Mil) | $511 | ($3) | 72% |
|
| Net Cash Flow (TTM) (Mil) | ($587) | $1 | 5% |
|
| Long-Term Debt (Q1) (Mil) | $930 | $21 | 65% |
|
| Enterprise Value (Q1) (Mil) | $10,075 | $427 | 74% |
|
| Valuation | PODD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 7.16 | 3.06 | 85% |
|
| P/E | 27.7 | 27.8 | 66% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.3 | 1.7 | 11% |
|
| Ratios | PODD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.1% | 58.9% | 82% |
|
| Net Margin | 12.3% | (6.9%) | 68% |
|
| ROA | 11.3% | (12.7%) | 89% |
|
| ROE | 26.0% | (13.1%) | 85% |
|
| Liabilities to Assets | 55.1% | 46.0% | 48% |
|
| F-Score | 9 | 4 | 98% |
|
Insulet Corporation did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
